We are incredibly proud of Sight Diagnostics for receiving FDA clearance for its OLO blood analyzer; OLO leverages AI with a revolutionary method to “digitize” blood, allowing patients to receive blood test results within minutes at the point-of-care, and with just a finger-prick. OurCrowd has been very excited about Sight Diagnostics from early on, and we are looking forward to celebrating continued innovation and success together.
Over the weekend on Fox Business News, Stifel CEO Ron Kruszewski explained why the investment banking firm partnered with OurCrowd. Watch here.
In other news, 147 nations in the UN General Assembly voted in favor of an Israel initiated resolution to help improve access to agtech capabilities for developing countries. This is another reason why we are so glad to back Israeli agtech companies like Consumer Physics, CropX, Taranis, Tevel, and more.